Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert M Califf

Showing results (351-360 of 770) with videos related to

Pageof 77
Sort By:
Diabetes Care|August 16, 2020
Benchmarking the Cost-Effectiveness of Interventions Delaying Diabetes: A Simulation Study Based on NAVIGATOR DataJose Leal, Shelby D Reed, Rishi Patel, et al.
Circulation. Heart Failure|March 10, 2015
Utility of socioeconomic status in predicting 30-day outcomes after heart failure hospitalizationZubin J Eapen, Lisa A McCoy, Gregg C Fonarow, et al.
Journal of Nursing Scholarship : an Official Publication of Sigma Theta Tau International Honor Society of Nursing|February 21, 2012
An academic-health service partnership in nursing: lessons from the fieldBradi B Granger, Janet Prvu-Bettger, Julia Aucoin, et al.
The American Journal of Cardiology|July 7, 2009
Usefulness of beta blockers in high-risk patients after myocardial infarction in conjunction with captopril and/or valsartan (from the VALsartan In Acute Myocardial Infarction [VALIANT] trial)Robert M Califf, Yuliya Lokhnygina, Eric J Velazquez, et al.
JAMA Cardiology|July 18, 2019
Effect of Simvastatin-Ezetimibe Compared With Simvastatin Monotherapy After Acute Coronary Syndrome Among Patients 75 Years or Older: A Secondary Analysis of a Randomized Clinical TrialRichard G Bach, Christopher P Cannon, Robert P Giugliano, et al.
American Heart Journal|March 29, 2008
Estimated glomerular filtration rate, inflammation, and cardiovascular events after an acute coronary syndromeLisa M Mielniczuk, Marc A Pfeffer, Eldrin F Lewis, et al.
Circulation|July 19, 2006
Clinical relevance of C-reactive protein during follow-up of patients with acute coronary syndromes in the Aggrastat-to-Zocor TrialDavid A Morrow, James A de Lemos, Marc S Sabatine, et al.
Circulation|May 4, 2005
Lower serum sodium is associated with increased short-term mortality in hospitalized patients with worsening heart failure: results from the Outcomes of a Prospective Trial of Intravenous Milrinone for Exacerbations of Chronic Heart Failure (OPTIME-CHF) studyLiviu Klein, Christopher M O'Connor, Jeffrey D Leimberger, et al.
Archives of Pediatrics & Adolescent Medicine|December 10, 2009
Safety and transparency of pediatric drug trialsDaniel K Benjamin, P Brian Smith, M Jessica M Sun, et al.
The American Journal of Cardiology|March 19, 2002
Underuse of aspirin in a referral population with documented coronary artery diseaseRobert M Califf, Elizabeth R DeLong, Truls Ostbye, et al.
Pageof 77

Showing results (351-360 of 770) with videos related to

Sort By:
Pageof 77
Diabetes Care|August 16, 2020
Benchmarking the Cost-Effectiveness of Interventions Delaying Diabetes: A Simulation Study Based on NAVIGATOR DataJose Leal, Shelby D Reed, Rishi Patel, et al.
Circulation. Heart Failure|March 10, 2015
Utility of socioeconomic status in predicting 30-day outcomes after heart failure hospitalizationZubin J Eapen, Lisa A McCoy, Gregg C Fonarow, et al.
Journal of Nursing Scholarship : an Official Publication of Sigma Theta Tau International Honor Society of Nursing|February 21, 2012
An academic-health service partnership in nursing: lessons from the fieldBradi B Granger, Janet Prvu-Bettger, Julia Aucoin, et al.
The American Journal of Cardiology|July 7, 2009
Usefulness of beta blockers in high-risk patients after myocardial infarction in conjunction with captopril and/or valsartan (from the VALsartan In Acute Myocardial Infarction [VALIANT] trial)Robert M Califf, Yuliya Lokhnygina, Eric J Velazquez, et al.
JAMA Cardiology|July 18, 2019
Effect of Simvastatin-Ezetimibe Compared With Simvastatin Monotherapy After Acute Coronary Syndrome Among Patients 75 Years or Older: A Secondary Analysis of a Randomized Clinical TrialRichard G Bach, Christopher P Cannon, Robert P Giugliano, et al.
American Heart Journal|March 29, 2008
Estimated glomerular filtration rate, inflammation, and cardiovascular events after an acute coronary syndromeLisa M Mielniczuk, Marc A Pfeffer, Eldrin F Lewis, et al.
Circulation|July 19, 2006
Clinical relevance of C-reactive protein during follow-up of patients with acute coronary syndromes in the Aggrastat-to-Zocor TrialDavid A Morrow, James A de Lemos, Marc S Sabatine, et al.
Circulation|May 4, 2005
Lower serum sodium is associated with increased short-term mortality in hospitalized patients with worsening heart failure: results from the Outcomes of a Prospective Trial of Intravenous Milrinone for Exacerbations of Chronic Heart Failure (OPTIME-CHF) studyLiviu Klein, Christopher M O'Connor, Jeffrey D Leimberger, et al.
Archives of Pediatrics & Adolescent Medicine|December 10, 2009
Safety and transparency of pediatric drug trialsDaniel K Benjamin, P Brian Smith, M Jessica M Sun, et al.
The American Journal of Cardiology|March 19, 2002
Underuse of aspirin in a referral population with documented coronary artery diseaseRobert M Califf, Elizabeth R DeLong, Truls Ostbye, et al.
Pageof 77